BioTrax AI

What BioTrax AI does

BioTrax AI, Inc., founded in 2025 in Palo Alto, California, operates an AI-powered longitudinal health platform built for precision longevity medicine. The platform ingests multimodal clinical, biomarker, wearable, and EHR data to construct a "Patient Digital Twin" model spanning ten health systems (cardiovascular, metabolic, inflammatory, hormonal, organ function, nutritional status, and others) and tracks 100+ biomarkers over time. Built-in clinical features include an Ambient AI Scribe for automated documentation, an AI Knowledge Companion for evidence-based point-of-care answers, Biomarker Intelligence for cross-lab pattern surfacing, and predictive analytics that estimate biological age and cardiovascular risk (using PREVENT equations). The technical stack is described as agentic AI on scalable HIPAA-compliant cloud infrastructure.

The company monetizes through two parallel channels. For clinicians, it sells a subscription SaaS platform with two tiers — Launch (AI biomarker intelligence, integrated lab ordering and at-home delivery, Patient Digital Twin) and Growth (adding Ambient AI Scribe, AI knowledge copilot, customizable protocols, and practice optimization). Pricing for clinical plans is customized by practice size and is not publicly disclosed. For individuals, BioTrax AI operates a direct-to-consumer membership model with three tiers (Curious, Enthusiast, Premium), priced at deep founding-member discounts ($12–$349/year) versus regular prices of $29–$399/year, with biomarker panels, the Digital Twin, and health coaching layered by tier. Go-to-market combines a sales-led, demo-based motion for clinical practices with a waitlist-driven self-serve motion for consumers, supported by a CME-accredited physician education platform. The company reports no disclosed funding, no named customers, and no app-store presence; operations are US-only and the founding team consists of a physician-CEO (former Kaiser Permanente Medical Director with 20+ years of experience) and a technologist-CTO (former Amazon VP with 40+ granted patents and two prior VC-backed exits).

Revenue is not disclosed; current activity — early-access request forms, waitlist signups, discounted founding-member pricing, and founder-controlled ownership — is consistent with pre-revenue, pre-traction stage rather than commercial scale. BioTrax AI's strategic intent combines physician credibility (CME-accredited content, clinician-validated workflows, HIPAA-compliant architecture), a talent-anchored founding team, and a vertically specialized product surface distinct from generalist EHR or population-health tools, with the objective of becoming the operating layer for the emerging precision longevity medicine category.

Name

BioTrax AI

Legal name

Biotrax AI, Inc.

Website

https://biotrax.ai

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

BioTrax AI is a Palo Alto-based, physician-and-AI-expert-founded company that sells an AI-driven longitudinal health platform (Patient Digital Twin, biomarker intelligence, ambient AI scribe) to clinical practices and a tiered direct-to-consumer membership to individuals for precision longevity medicine.

Ownership category

akta.pro rank

Product category

Precision Longevity Medicine Software

akta.pro industry

PRIMARYHLAAALAO

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

SECONDARYHLACAPAB

Connected Medical Devices & Wearables (Sensors, Patches, Implantables)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLACAPAD

Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

• Precision longevity medicine
• Clinical biomarker analytics
• Digital twin health
• Wearable health integration
• Longevity practice software

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Clinical Platform Subscription: Subscription-based SaaS platform for precision longevity medicine practices. Two tiers: Launch and Growth plans, customized by practice size and services. Includes AI-powered biomarker intelligence, longitudinal insights, lab integration, patient Digital Twin, ambient AI scribe, knowledge copilot, and practice optimization tools depending on tier.
2. Individual Membership Subscription: Three-tier consumer membership model: Curious (basic health tracking, wearable integration), Enthusiast (adds biomarker panel, Digital Twin, personalized recommendations), and Premium (adds advanced testing, health coaching session). Annual billing with founding member pricing discounts. Individual biomarker tests available on-demand.
3. Biomarker Testing Services: Integrated lab test ordering and at-home delivery generates revenue through expanded testing programs. Practices can offer precision health and longevity biomarker panels to patients as an additional revenue stream without adding headcount.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

BioTrax AI is an AI-powered longitudinal health platform that turns fragmented biomarker, wearable, and clinical data into a continuously updated Digital Twin of each patient across 10 health systems, enabling precision longevity medicine practices to deliver proactive, data-driven care. For clinicians it offers AI-generated pre-visit summaries, ambient AI scribing, biomarker pattern recognition, evidence-based clinical Q&A, integrated lab ordering, and biological age / cardiovascular risk scoring; for individual consumers it offers tiered memberships with health tracking, biomarker panels, Digital Twin access, and AI-powered lifestyle recommendations.

Product overview

BioTrax AI is a unified longitudinal health platform for precision longevity medicine, serving both clinical practices and individual health consumers. For clinical practices, the platform offers two membership tiers: Launch Plan (AI-powered biomarker intelligence, lab test ordering, and Patient Digital Twin) and Growth Plan (adds Agentic AI scribe, AI knowledge copilot, customizable protocols, and practice optimization). For individual consumers, three membership tiers are offered: Curious (basic health tracking), Enthusiast (annual biomarker panel, Digital Twin, AI insights), and Premium (advanced testing, health coaching). The core platform is built around a Patient Digital Twin that integrates biomarker data, wearable data, and clinical history across 10 health systems to generate biological age estimates, risk scores, and actionable clinical insights. Clinical-grade features include Ambient AI Scribe for documentation, AI Knowledge Companion for evidence-based answers, and predictive analytics for biological age and cardiovascular risk scoring.

Differentiator

Problem solved

Functional benefit

Products and services

• BioTrax AI Clinical Platform

Quantifiable outcome

• Reduction in admin time: hours of manual chart review eliminated per week through AI-assisted preparation and automated patient summaries
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature8 records

Partnerships

One partnership is on record.

• Gloucester VenturesminorGTM or Marketing PartnerBioTrax AI was featured in Gloucester Ventures' whitepaper 'How AI is catalyzing new precision diagnostics that deserve greater investor attention.' The whitepaper highlighted BioTrax AI as a platform transforming fragmented biomarker testing into predictive, personalized care. This coverage positions BioTrax AI in the investor and venture community landscape for precision diagnostics.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Function Health: Function Health is a direct-to-consumer longevity platform offering comprehensive biomarker testing (100+ markers) with practitioner partnerships. It is the most direct competitor to BioTrax on the consumer biomarker interpretation side, with overlapping product framing and target customer.
• InsideTracker: InsideTracker delivers personalized biomarker analysis with food and supplement recommendations, serving both individual consumers and wellness programs. It competes head-to-head with BioTrax on longitudinal biomarker interpretation and lifestyle insight, with a longer operating history.
• Tally Health: TallyHealth offers at-home biological age testing and longevity programs targeting health-conscious consumers. It overlaps directly with BioTrax's biological age and digital twin value proposition and competes for the same premium consumer willingness-to-pay segment.
• Marek Health: Marek Health is a telehealth and longevity medicine platform serving both clinicians and patients with hormone optimization, biomarker testing, and ongoing care programs. It mirrors BioTrax's B2B2C longevity positioning and shares the same clinician-plus-consumer customer base.

Emerging players

• Prenuvo: Prenuvo offers whole-body MRI screening and longevity-focused health assessments for proactive consumers. It overlaps with BioTrax on the premium longevity screening customer and the broader thesis of preventive, data-rich care.
• Levels Health: Levels Health provides continuous glucose monitoring-based metabolic insights for individuals and programs. It is a partial overlap with BioTrax on biomarker-driven lifestyle recommendations and serves a similar health-conscious consumer base.
• Deep Longevity: Deep Longevity (now part of Endothelix) develops AI-driven biomarkers of aging and biological age models using blood and clinical data. It competes with the AI interpretation layer of BioTrax's Digital Twin and is focused on a narrower aging-clock product.

Broad incumbents

• Elysium Health: Elysium Health is an established longevity science company with consumer supplements and the Elysium Index biological age test. It is a broader incumbent in the longevity category with deeper R&D resources and consumer brand awareness than BioTrax.
• Verily Life Sciences: Verily (an Alphabet company) operates broadly in precision health, including chronic disease management, clinical research platforms, and wearable-driven health programs. It is a much larger incumbent that intersects with BioTrax's preventive, biomarker-driven care thesis at scale.
• Thorne: Thorne is an established supplements and health-testing brand offering at-home biomarker tests and a practitioner line. It is a broader incumbent in the longevity/wellness category with greater scale and brand recognition, partially overlapping with BioTrax's biomarker testing and clinician relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biotraxai

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioTrax AI